Gastric cáncer: prognostic factors
DOI:
https://doi.org/10.37910/RDP.2025.14.2.e425Keywords:
Gastric cancer, Prognostic factors, Survival, Relapse, RecurrenceAbstract
Prognostic factors are variables related to the patient, the tumor and the surgical treatment, which allow us to predict the evolution of the disease. Objective: To describe the prognostic factors in patients diagnosed with gastric cancer treated at the Digestive Tract Surgery Service of the Instituto de Oncología Luis Razetti, in Caracas, from january 2008 to december 2021. Methods: The study is a case review, descriptive, cross-sectional and observational. The mean and standard deviation were calculated for the quantitative variables, and the frequency and percentage were calculated for the qualitative variables. Survival curves were constructed using the Kaplan-Meier model. Results: 46 patients with gastric cancer were evaluated. The average age was 58 ± 11 years. In the analysis of overall and disease-free survival, the statistically significant variables were: lymph vascular invasion, type of resection, type of dissection, and number of affected nodes. The significant variables for relapse were: lymph vascular invasion and type of surgery
Downloads
References
1. National Comprehensive Cancer Network. [en línea]. NCCN Clinical Practice Guidelines in Oncology. Gastric cancer Version 2.2021. [actualizado marzo 9, 2021; citado 25 abril 2021]. Disponible en: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf.
2. Siegel R, Miller K, Jemal A. Cancer statistics, 2020. CA Cancer J Cli. [en línea]. 2020 [citado 25 abril 2021]; 70(1): 7-30.Nesbit M. Clinical assessment and differential diagnosis of the childwith suspected cancer. En Pizzo P., Poplack D eds. Principles and Practice of Pediatric Oncology. Philidelphia. JB Lippincott.1989: 83-92.
3. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski W. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. [en línea]. 2018 [citado 25 abril 2021]; 10:239-
24. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29445300/4. Villafranca E, Aristu J, Meiriño R, Dueñas MT, Marcos M. Factores pronósticos del carcinoma gástrico. Anales Sis San Navarra [en línea]. 2001 [citado 25 abril 2021]; 24(1): 111-120. Disponible en: https://recyt.fecyt.es/index.php/ASSN/article/view/5841.
5. National Cancer Institute. Cancer Stat Facts: Stomach cancer [en línea]. 2021 [citado 25 abril 2021]. Disponible en: https://seer.cancer.gov/statfacts/html/stomach.html
6. Rodríguez Z, Piña L, Manzano E, Cisneros CM, Fernández W. Factores pronósticos relacionados con el cáncer gástrico. Revista Cubana de Cirugía [en línea]. 2011 [citado 25 abril 2021]; 50(3): 363-387. Disponible en: http://scielo.sld.cu/pdf/cir/v50n3/cir15311.pdf
7. Roder J, Bottcher K, Rudiger Siewert J, Busch R, Hermanek P, Meyer HJ. Prognostic Factors in Gastric Carcinoma. Results of the German Gastric Carcinoma Study 1992. CANCER [en línea]. 1993 [citado 25 abril 2021]; 72(7): 2089-2097. Disponible en: https://pubmed.ncbi.nlm.nih.gov/8374867/
8. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer [en línea]. 1998 [citado 25 abril 2021]; 1: 125-133. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11957056.
9. Siewert JR, Bottcher K, Stein HJ, Roder JD, and the German Gastric Carcinoma Study Group. Relevant prognostic factors in gastric cáncer. Ten-year results of the German Gastric Cancer Study. Ann. Surg. [en línea]. 1998 [citado 25 abril 2021]; 228(4): 449-461. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1191515/
10. Park JM, Ryu WS, Kim JH, Park SS, Kim SJ, Kim CS, et al. Prognostic factors for advanced gastric cancer: stage-stratified analysis of patients who underwent curative resection. Cancer Res Treat. [en línea]. 2006 [citado 25 abril 2021]; 38(1): 13-18. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19771253/
11. Medrano R, Valencia D, Luna M, García LE, González D. Prognostic factors for survival in patients with resectable advanced gastric adenocarcinoma. Cir Cir. [en línea]. 2016 [citado 25 abril 2021]; 84(6):469-476. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27039288/
12. Zhou Y, Cui JG, Huang F, Zhang A, Li C, Zhao ZC, et al. Prognostic factors for survival in node-negative gastric cancer patients who underwent curative resection. Scandinavian Journal of Surgery [en línea]. 2017 [citado 5 mayo 2021]; 106(3):35–240. Disponible en: https://journals.sagepub.com/doi/pdf/10.1177/1457496916677878
13. Itaimi A, Baraket O, Triki W, Ayed K, Bouchoucha S. Prognostic factors affecting survival and recurrence in gastric carcinoma. Cancer Rep Rev. [en línea]. 2018 [citado 25 abril 2021]; 2(6):-4. Disponible en: file:///C:/Users/NB-3300/Downloads/Prognostic_factors_affecting_survival_and_recurren.pdf
14. Galvis L, Delgado R, Luces C, Taronna I, Pinto S, Gotera G, et al. Neoadyuvancia en cáncer gástrico avanzado. Factores pronósticos de respuesta tumoral. Rev Venez Oncol. [en línea]. 2019 [citado 25 abril 2021]; 31(2): 84-93. Disponible en: https://www.redalyc.org/jatsRepo/3756/375658206002/html/index.html
15. Alshehri A, Alanezi H, Su Kim B. Prognosis factors of advanced gastric cancer according to sex and age. World J Clin Cases [en línea]. 2020 [citado 25 abril 2021]; 8(9): 1608-1619. Disponible en: https://www.wjgnet.com/2307-8960/full/v8/i9/1608.htm
16. Yaprak G, Tataroglu D, Dogan B, Pekyurek M. Prognostic factors for survival in patients with gastric cancer: Single-centre experience. North Clin Istanb. [en línea]. 2020 [citado 5 mayo 2021]; 7(2): 146–152. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117626/pdf/NCI-7-146.pdf
17. Drake R, Vogl W, Mitchell A. Gray anatomía para estudiantes. Madrid: Elsevier; 2007.
18. Hopkings. Health. Gastric cáncer. Overview. Página web. Disponible en: https://www.hopkinsmedicine.org/health/conditions-and-diseases/stomach-gastric-cancer.
19. Stadtlander C, Waterbor W. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis [en línea]. 1999 [citado 2 mayo 2021]; 20(12): 2195-2207. Disponible en: https://pubmed.ncbi.nlm.nih.gov/10590210/
20. Tan P, Yeoh KG. Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma. Gastroenterology [en línea]. 2015 [citado 2 mayo 2021]; 149(5): 1153–1162. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26073375/
21. Parra JF, Hernández R, Gil A, Uzcátegui N, Honorato A, Barrios R, et al. Cáncer gástrico. Primera reunión de consenso. Agosto 2006. Revista Venezolana de Oncología [en línea]. 2007;19(2):166-190. Disponible en: https://www.redalyc.org/articulo.oa?id=375635126013.
22. Kang W, Zhang J, To KF. Molecular Pathogenesis of Gastric Adenocarcinoma. In: IntechOpen. Stomach Disorders [en línea]. 2018 [citado 2 mayo 2021] 7-21. Disponible en: https://www.intechopen.com/books/stomach-disorders/molecular-pathogenesis-of-gastricadenocarcinoma.
23. Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, et al. The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer [en línea]. 2015 [citado 4 junio 2022]; 15: 370. Disponible en: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-1370-2.
24. Park JH, Ryu MH, Kim HJ, Ryoo BY, Yoo C, Park I, et al. Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer. Gastric Cancer [en línea]. 2016 [citado 4 junio 2022]; 19: 226–233. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25614467/
25. Zhang CD, Ning FL, Zeng XT, Dai DQ. Lymphovascular invasion as a predictor for lymph node metastasis and a prognostic factor in gastric cancer patients under 70 years of age: A retrospective analysis. International Journal of Surgery [en línea]. 2018 [citado 4 junio 2022]; 53: 214–220. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29609047/
26. Choi WH, Kim MJ, Park JH, Kang JG, Seo SI, Kim HY, et al. Lymphatic invasion might be considered as an upstaging factor in N0 and N1 gastric cancer. J. Clin. Med. [en línea]. 2020 [citado 4 junio 2022]; 9(5):1275. Disponible en: https://www.mdpi.com/2077-0383/9/5/1275/htm
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Carmen Luces, Gustavo Gotera, Armando Gil
This work is licensed under a Creative Commons Attribution 4.0 International License.
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y construir a partir del material
- para cualquier propósito, incluso comercialmente.
Bajo los siguientes términos:
-
Atribución — Usted debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
- No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
